Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 11 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Ani Pharmaceuticals Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +10 vs. Q1 2021
- Shares held
- 7.21M
- −79.8K (−1.1%) vs. Q1 2021
- Total value
- $252.7M
- −$10.8M (−4.1%) vs. Q1 2021
- New holders
- 18
- 37 more added
- Sold out
- 8
- 39 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Massmutual Trust Co FSB | 48 | $2.00K | 0.00% | +48 | New |
| Captrust Financial Advisors | 29 | $1.00K | 0.00% | −20−40.8% | Reduced |
| US Bancorp | 25 | $1.00K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 23 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 27 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 20 | $1.00K | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 30 | $1.00K | 0.00% | 00.0% | Unchanged |
| Sageworth Trust Co | 40 | $1.00K | 0.00% | +40 | New |
| Versant Capital Management, Inc | 40 | $1.00K | 0.00% | +40 | New |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 12 | $0 | 0.00% | +12 | New |
| Gradient Investments LLC | 1 | $0 | 0.00% | +1 | New |
| Sargent Bickham Lagudis LLC | 13 | $0 | 0.00% | +13 | New |
| McClarren Financial Advisors, Inc. | 3 | $0 | 0.00% | +3 | New |
| Alaethes Wealth LLC | 10 | $0 | 0.00% | +10 | New |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −6,229−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,724−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| RMR Wealth Builders | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |